Insider Trading News

Standex (SXI) director Thomas Chorman sells $14,244 in shares

By Investing.com2 min readInvesting.com
Standex (SXI) director Thomas Chorman sells $14,244 in sharesStandex (SXI) director Thomas Chorman sells $14,244 in shares

Standex (SXI) director Thomas Chorman sells $14,244 in shares

Thomas E. Chorman, a director at Standex International Corp. (NASDAQ:SXI), sold 50 shares of the company’s common stock on September 1, 2026. The transaction resulted in a total value of $14,244.

The shares were sold at a price of $284.89 per share. This sale was conducted pursuant to an existing 10b5-1 trading plan, which was established on November 6, 2025. Following this transaction, Mr. Chorman directly beneficially owns 12,316 shares of Standex common stock.The sale comes as Standex shares have declined 8.3% over the past week, with the stock currently trading at $274.94. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value. Investors seeking deeper insights can access 11 additional InvestingPro Tips and comprehensive analysis through the platform’s Pro Research Report, available for SXI and 1,400+ other US equities.

In other recent news, Standex International reported fiscal fourth-quarter 2026 adjusted earnings of $2.45 per share on revenue of $228.25 million, surpassing Wall Street expectations. The company achieved record annual margins and strong cash flow, with a positive outlook for fiscal 2027, particularly in electronics, aerospace, and grid infrastructure sectors. Following these results, DA Davidson raised its price target for Standex International to $350 from $323, maintaining a Buy rating on the stock. This adjustment reflects the company’s organic growth of 7.7% in the quarter, an increase from the previous quarter’s 6.5% growth rate. DA Davidson hosted investor meetings with Standex’s CEO, David Dunbar, across multiple cities, reaffirming their confidence in the company’s growth prospects. These developments highlight Standex International’s recent performance and future potential according to analyst assessments.